Company Announcements

Zymoic announced in October that it is now selling Skycam HPLC and IC systems in the US.

Showa Denko named Kohei Morikawa as president and CEO, effective January 4, 2017. He is currently director, managing corporate officer and CTO. Current President and CEO Hideo Ichikawa will become a representative director and chairman.

In November, Waters announced a comarketing and reseller agreement with SOTAX, a provider of dissolution testing, automated sample preparation and physical testing of pharmaceutical dosage forms. Waters made available to SOTAX its ACQUITY HPLC H-Class System for sale to drug manufacturers performing small molecule, solid-dosage analysis in QC and analytical R&D. Waters licensed SOTAX as an independent distributor in the US, Canada, UK, France, Germany, Italy, Switzerland and the Czech Republic.

Novasep announced in November an extension of its partnership with AR Brown to include the commercialization of its chromatography systems for the Japanese pharmaceutical industry. AR Brown provides business development and technical services. Allied Labs will continue to provide equipment maintenance services for the systems in Japan.

In November, Natrix Separations announced a development agreement with Merck and Sanofi to advance its new membrane-based Protein A platform for antibody purification. Natrix also announced an agreement with Scil Proteins for the engineering and development of the Protein A ligand that will be integrated with Natrix’s membrane technology.

Product Introductions

In October, Phenomenex introduced the Luna Omega Polar C18 stationary phase in a high performance 1.6 µm particle for UHPLC and a low pressure 5 µm particle for direct scalability to analytical HPLC from preparative work. They deliver a wide elution window and combined high retention for polar and nonpolar analytes. The company also released the Luna Omega PS C18 with mixed-mode selectivity.

In November, as part of its Clarity BioSolutions portfolio, Phenomenex released two new particle chemistries for characterization and purification of synthetic oligonucleotides: the core-shell Clarity Oligo-XT for reversed-phase LC analysis and purification, and the nonporous Clarity Oligo-XAS, a strong anion exchanger for characterization.

Waters introduced in November two new chemistries for its CORTECS Columns product line. CORTECS T3 features an increased pore diameter (120 Å vs. 90 Å) along with lower C18 ligand density and proprietary end capping. The Shield RP18 columns utilize an embedded carbamate functional group into the alkyl ligand, which provides alternative selectivity for basic and polyphenolic compounds when compared to typically bonded C18 phases.

Shimadzu launched in November the Nexera UC/s (SFC/HPLC Switching System) for LC and SFC on a single system. LC units already installed can be upgraded to the Nexera UC/s at a cost of approximately half the price of a new SFC.

Biotage launched in December the Biotage SNAP Bio C18 and Biotage SNAP Bio C4 flash cartridges for peptide purification, featuring wide pore media (300 Å).